Oppenheimer Starts Crinetics (CRNX) at Outperform, 'Building Endocrine Medicine's Future, One Small Molecule at a Time'
Tweet Send to a Friend
(Updated - August 30, 2023 4:03 PM EDT)
Oppenheimer analyst Leland Gershell initiates coverage on Crinetics (NASDAQ: CRNX) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershell initiates coverage on Crinetics (NASDAQ: CRNX) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
